Medtronic has inaugurated a new Global Capability Centre (GCC) in Pune, India, for its Diabetes business. Over the next five years, an investment of $50 million will support the establishment and expansion of the new centre.
The Diabetes GCC will be a centre of excellence that aims to enhance customer care, advanced analytics, and digital tech services, while also supporting patient financial services and operations. The centre also aims to create over 300 service and software jobs in the first year of operations, with plans to double this number over the next four years.
Medtronic recently announced its intent to separate the Diabetes business into an independent, standalone publicly traded company, which will be called MiniMed once it begins operating as a standalone business.
